Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine.
| Title | Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine. |
| Publication Type | Journal Article |
| Year of Publication | 2014 |
| Authors | Miltiades, P., Lamprianidou E., Vassilakopoulos T. P., Papageorgiou S. G., Galanopoulos A. G., Vakalopoulou S., Garypidou V., Papaioannou M., Hadjiharissi E., Pappa V., Papadaki H. A., Spanoudakis E., Tsatalas K., & Kotsianidis I. |
| Journal | Blood Cancer J |
| Volume | 4 |
| Pagination | e187 |
| Date Published | 2014 |
| ISSN | 2044-5385 |
| DOI | 10.1038/bcj.2014.9 |
| Alternate Journal | Blood Cancer J |
| PubMed ID | 24583533 |
| PubMed Central ID | PMC3944665 |
